The animal studies are the basis for Food and Drug Administration warnings that both Ozempic approved only for diabetes but used off-label for weight loss as well as the higher-dose obesity formulation, Wegovy, should be discontinued at least two months prior to pregnancy
Examples of GLP-1 receptor agonists and related medications include: Wegovy (semaglutide) Mounjaro (tirzepatide) Saxenda (liraglutide) Ozempic (semaglutide) used to treat type 2 diabetes Trulicity (dulaglutide) used to treat type 2 diabetes Do not use Wegovy together with another GLP-1 receptor agonist
Importantly, the sema peptide does not typically stimulate insulin when blood glucose is low, reducing the risk of hypoglycemia in research models
**Appetite Control**: Semaglutide helps reduce your appetite by acting on the brain regions responsible for hunger
People with a history of pancreatitis, diabetic retinopathy, or severe gastrointestinal disease should discuss these conditions carefully before use
Your treatment may also include diet, exercise, weight control, medical tests, and special medical care
